Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients

Simplified diagram of methodology. Blood samples were collected from 45 patients with breast cancer (BC): 30 were luminal A and 15 were triple-negative breast cancer patients (TNBC). Peripheral blood mononuclear cells (PBMCs) were isolated from blood and stored at −80 °C for future use. Monocytes were extracted from PBMCs using a MojoSort monocyte isolation kit and then differentiated into tumor-associated macrophages (TAMs). Thymoquinone (TQ) stock solution was prepared in dimethyl sulfoxide (DMSO) and was diluted with fresh culture media just before use. According to the literature, 20, 50, and 100 µM concentrations were prepared. PBMCs and TAMs were cultured with the aforementioned TQ concentrations for 24, 48, and 72 h. RNA isolation was conducted with RNeasy Mini Kit (QIAGEN) and then converted into cDNA in the thermocycler. Finally, RT-PCR was used to quantify calreticulin, NLRP3, PYCARD, caspase-1, and IL-1β. Relative Quantitation (RQ) values were calculated and plotted on the Y-axis against TQ concentrations. The cell culture supernatants were used to measure the secreted protein levels of IL-1β and sPD-L1 via ELISA. The expression and protein levels were compared to the DMSO control. All experiments were performed in triplicate and data were expressed as the mean ± standard deviation. Statistical analysis was performed using the GraphPad Prism software version 9.1.1. The data were analyzed using one-way ANOVA, Dunnett’s multiple comparisons, and unpaired t-test.
Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients

Publication

Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients. (2023) Sawsan Elgohary, et al. Int J Mol Sci. 2023 Sep;24(18):14254. Figure: F9.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Danio rerio Vertebrates CALR CALR ncbigene_symbol calr 325317
Danio rerio Vertebrates CALR CALR ncbigene_synonym calr3a 30248
Danio rerio Vertebrates PYCARD PYCARD ncbigene_symbol pycard 57923
Danio rerio Vertebrates NLRP3 NLRP3 ncbigene_symbol nlrp3 567964
Danio rerio Vertebrates GAPDH GAPDH ncbigene_symbol gapdh 317743
Danio rerio Vertebrates GAPDH GAPDH ncbigene_synonym gapdhs 406367
Danio rerio Vertebrates IL-10 IL10 ncbigene_symbol il10 553957
Danio rerio Vertebrates IL-4, IL-4 ncbigene_synonym il13 794053
Danio rerio Vertebrates IL-4, IL-4 ncbigene_synonym il4 100188894
Homo sapiens Primates CALR CALR ncbigene_symbol CALR 811
Homo sapiens Primates PYCARD PYCARD ncbigene_symbol PYCARD 29108
Homo sapiens Primates NLRP3 NLRP3 ncbigene_symbol NLRP3 114548
Homo sapiens Primates GAPDH GAPDH ncbigene_symbol GAPDH 2597
Homo sapiens Primates GAPDH GAPDH ncbigene_synonym GAPDHP44 100240709
Homo sapiens Primates IL-10 IL-10 ncbigene_synonym IL10 3586
Homo sapiens Primates IL-4, IL-4 ncbigene_synonym IL4 3565
Homo sapiens Primates M-CSF,TCM MCSF ncbigene_synonym CSF1 1435
Homo sapiens Primates IL-18 IL-18 ncbigene_synonym IL18 3606

Chemical mentions

Word Match MeSH Name ChEBI
Thymoquinone thymoquinone mesh:C003466 thymoquinone chebi:113532
DMSO Dimethyl Sulfoxide mesh:D004121 dimethyl sulfoxide chebi:28262

Disease mentions

Word Match MeSH Name DOID